Synthetic Biologics Announces First Six Participants Dosed in Phase 1a Clinical Trial of SYN-020 …,

Phase 1 Clinical Program Intended to Support Development of SYN-020 in Multiple Indications, Including Treatment of Celiac Disease, Non-Alcoholic …, Phase 1 Clinical Program Intended to Support Development of SYN-020 in Multiple Indications, Including Treatment of Celiac Disease, Non-Alcoholic …, Read More

Scroll to Top